中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共4条，第1-4条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies 期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
作者:  Wu, Xiaofan;  Yang, Hongjian;  Yu, Xingfei;  Qin, Jiang-Jiang
收藏  |  浏览/下载：51/0  |  提交时间：2022/12/22
HER2  breast cancer  targeted therapy  drug resistance  overcoming strategies  
Cardiotoxicity of Epidermal Growth Factor Receptor 2-Targeted Drugs for Breast Cancer 期刊论文
FRONTIERS IN PHARMACOLOGY, 2021, 卷号: 12
作者:  Yang, ZiYan;  Wang, Wei;  Wang, Xiaojia;  Qin, ZhiQuan
收藏  |  浏览/下载：66/0  |  提交时间：2022/01/10
cardiotoxicity  ErbB2  targeting drugs  breast cancer  therapy  
PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy 期刊论文
FRONTIERS IN PHARMACOLOGY, 2021, 卷号: 12
作者:  Qi, Si-Min;  Dong, Jinyun;  Xu, Zhi-Yuan;  Cheng, Xiang-Dong;  Zhang, Wei-Dong;  Qin, Jiang-Jiang
收藏  |  浏览/下载：52/0  |  提交时间：2021/06/15
PROTAC  E3 ubiquitin ligase  protein degradation  ubiquitin-proteasome system  cancer therapy  
Identification of FPR3 as a Unique Biomarker for Targeted Therapy in the Immune Microenvironment of Breast Cancer 期刊论文
FRONTIERS IN PHARMACOLOGY, 2021, 卷号: 11
作者:  Qi, Jian;  Liu, Yu;  Hu, Jiliang;  Lu, Li;  Dou, Zhen;  Dai, Haiming;  Wang, Hongzhi;  Yang, Wulin
收藏  |  浏览/下载：44/0  |  提交时间：2021/04/26
breast cancer  immune microenvironment  ESTIMATE algorithm  immune checkpoint  FPR3